121.410 -

+2.170 (+1.82%)
Range 121.030 - 123.330   (1.90%)
Open 121.500
Previous Close 119.240
Bid Price -
Bid Volume -
Ask Price -
Ask Volume -
Volume 10,102,324
Value 691,071,399
Remark -
Delayed prices. Updated at 14 Feb 2026 09:15.
Data powered by
View All Events

About Merck & Co

Merck & Co., Inc. (Merck), is a global health care company that delivers health solutions through its prescription medicines, vaccines, biologic therapies, animal health, and consumer care products, which it markets directly and through its joint ventures. The Company consists of four operating segments, which are the Pharmaceutical, Animal Health, Consumer Care and Alliances segments, and one reportable segment, which is the Pharmaceutical segment. The Pharmaceutical segment includes human health pharmaceutical and vaccine products marketed either directly by the Company or through joint ventures. Human health pharmaceutical products consist of therapeutic and preventive agents, generally sold by prescription, for the treatment of human disorders. On July 2, 2014, Santen Pharmaceutical Co., Ltd acquired certain ophthalmology assets from Merck & Co., Inc. On August 5, 2014, Merck & Co Inc (Merck) acquired Idenix Pharmaceuticals Inc (Idenix).

There are 16 followers

Followers
0
Followers
0
Followers
0
Followers
0
Followers
0
Followers
0
Followers
0
Followers
0
Followers
4
Followers
0
Followers
0
Followers
1
Followers
2
Followers
2
Followers
0
Followers
0